Cargando…

Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia

BACKGROUND: Depression and anxiety disorders are common among people living with Human Immunodeficiency Virus than the non-infected individuals. The co-existence of these disorders are associated with barriers to treatment and worsening medical outcomes, including treatment resistance, increased ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesfaw, Getachew, Ayano, Getinet, Awoke, Tadesse, Assefa, Dawit, Birhanu, Zelalem, Miheretie, Getenet, Abebe, Genet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094082/
https://www.ncbi.nlm.nih.gov/pubmed/27806711
http://dx.doi.org/10.1186/s12888-016-1037-9
_version_ 1782465056425902080
author Tesfaw, Getachew
Ayano, Getinet
Awoke, Tadesse
Assefa, Dawit
Birhanu, Zelalem
Miheretie, Getenet
Abebe, Genet
author_facet Tesfaw, Getachew
Ayano, Getinet
Awoke, Tadesse
Assefa, Dawit
Birhanu, Zelalem
Miheretie, Getenet
Abebe, Genet
author_sort Tesfaw, Getachew
collection PubMed
description BACKGROUND: Depression and anxiety disorders are common among people living with Human Immunodeficiency Virus than the non-infected individuals. The co-existence of these disorders are associated with barriers to treatment and worsening medical outcomes, including treatment resistance, increased risk for suicide, greater chance for recurrence and utilization of medical resources and/or increase morbidity and mortality. Therefore, assessing depression and anxiety among HIV patients has a pivotal role for further interventions. METHODS: Institution based cross-sectional study was conducted at ALERT hospital May, 2015. Data were collected using a pretested, structured and standardized questionnaire. Systematic sampling technique was used to select the study participants. Binary logistic regression analysis was used to identify associated factors. Odds ratio with 95 % CI was computed to assess the strength of associations. RESULTS: The prevalence of co-morbid depression and anxiety among HIV patients was 24.5 % and prevalence of depression and anxiety among HIV patients was 41.2 % (172) and 32.4 % (135) respectively. Multivariate analysis showed that individual who had perceived HIV stigma (AOR = 3.60, 95 % CI (2.23, 5.80), poor social support (AOR = 2.02, 95 % CI (1.25, 3.27), HIV stage III (AOR = 2.80, 95 % CI (1.50, 5.21) and poor medication adherence (AOR = 1.61, 95 % CI (1.02, 2.55) were significantly associated with depression. Being female (AOR = 3.13, 95 % CI (1.80, 5.44), being divorced (AOR = 2.51, 95 % CI (1.26, 5.00), having co morbid TB (AOR = 2.74, 95 % CI (1.37, 5.47) and perceived HIV stigma (AOR = 4.00, 95 % CI (2.40, 6.69) were also significantly associated with anxiety. CONCLUSION: Prevalence of depression and anxiety was high. Having perceived HIV stigma, HIV Stage III, poor social support and poor medication adherence were associated with depression. Whereas being female, being divorced and having co morbid TB and perceived HIV stigma were associated with anxiety. Ministry of health should give training on how to screen anxiety and depression among HIV patients and should develop guidelines to screen and treat depression and anxiety among HIV patients.
format Online
Article
Text
id pubmed-5094082
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50940822016-11-07 Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia Tesfaw, Getachew Ayano, Getinet Awoke, Tadesse Assefa, Dawit Birhanu, Zelalem Miheretie, Getenet Abebe, Genet BMC Psychiatry Research Article BACKGROUND: Depression and anxiety disorders are common among people living with Human Immunodeficiency Virus than the non-infected individuals. The co-existence of these disorders are associated with barriers to treatment and worsening medical outcomes, including treatment resistance, increased risk for suicide, greater chance for recurrence and utilization of medical resources and/or increase morbidity and mortality. Therefore, assessing depression and anxiety among HIV patients has a pivotal role for further interventions. METHODS: Institution based cross-sectional study was conducted at ALERT hospital May, 2015. Data were collected using a pretested, structured and standardized questionnaire. Systematic sampling technique was used to select the study participants. Binary logistic regression analysis was used to identify associated factors. Odds ratio with 95 % CI was computed to assess the strength of associations. RESULTS: The prevalence of co-morbid depression and anxiety among HIV patients was 24.5 % and prevalence of depression and anxiety among HIV patients was 41.2 % (172) and 32.4 % (135) respectively. Multivariate analysis showed that individual who had perceived HIV stigma (AOR = 3.60, 95 % CI (2.23, 5.80), poor social support (AOR = 2.02, 95 % CI (1.25, 3.27), HIV stage III (AOR = 2.80, 95 % CI (1.50, 5.21) and poor medication adherence (AOR = 1.61, 95 % CI (1.02, 2.55) were significantly associated with depression. Being female (AOR = 3.13, 95 % CI (1.80, 5.44), being divorced (AOR = 2.51, 95 % CI (1.26, 5.00), having co morbid TB (AOR = 2.74, 95 % CI (1.37, 5.47) and perceived HIV stigma (AOR = 4.00, 95 % CI (2.40, 6.69) were also significantly associated with anxiety. CONCLUSION: Prevalence of depression and anxiety was high. Having perceived HIV stigma, HIV Stage III, poor social support and poor medication adherence were associated with depression. Whereas being female, being divorced and having co morbid TB and perceived HIV stigma were associated with anxiety. Ministry of health should give training on how to screen anxiety and depression among HIV patients and should develop guidelines to screen and treat depression and anxiety among HIV patients. BioMed Central 2016-11-02 /pmc/articles/PMC5094082/ /pubmed/27806711 http://dx.doi.org/10.1186/s12888-016-1037-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tesfaw, Getachew
Ayano, Getinet
Awoke, Tadesse
Assefa, Dawit
Birhanu, Zelalem
Miheretie, Getenet
Abebe, Genet
Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia
title Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia
title_full Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia
title_fullStr Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia
title_full_unstemmed Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia
title_short Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia
title_sort prevalence and correlates of depression and anxiety among patients with hiv on-follow up at alert hospital, addis ababa, ethiopia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094082/
https://www.ncbi.nlm.nih.gov/pubmed/27806711
http://dx.doi.org/10.1186/s12888-016-1037-9
work_keys_str_mv AT tesfawgetachew prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia
AT ayanogetinet prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia
AT awoketadesse prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia
AT assefadawit prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia
AT birhanuzelalem prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia
AT miheretiegetenet prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia
AT abebegenet prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia